Taking a high dose of vitamin D could be an inexpensive and easy way to treat people with multiple sclerosis (MS), an autoimmune disorder that affects brain and spinal chord, suggests a promising new research.
Patients with severe vitamin D deficiency were not included in the study. Blood tests at the start of the study and again at three and six months measured the amount of vitamin D in the blood and the response in the immune system's T cells, which play a key role in MS. While researchers are still determining the optimal level of vitamin D in the blood for people with MS, a suggested range of 40 to 60 nanograms per milliliter (ng/ml) has been proposed as a target.Participants taking high doses of vitamin D reached levels within the proposed target, whereas the group taking the low dose did not reach the target. Those taking high dose had a reduction in the percentage of inflammatory T cells related to MS severity.Side effects from the vitamin supplements were minor and did not differ different between those taking high dose and the ones who took low dose, the study found.The study was published online in the journal of Neurology.
"Certainty Is A Problem": Nikhil Kamath On Marriage, Children And Future
The Mystery Of A Bare Nail In Ashwini Vaishnaw's Office
Paris Setback, Asian Games Glory: Lovlina Borgohain's New Perspective
'AI Scares Me': Kriti Sanon On Personality Rights And Need For Laws
'This Time I Wanted Gold': Savita Punia Reflects On Historic Asiad Success
Neha Goyal Makes Stunning Asian Games Gold Revelation At NDTV World Summit 2026
RBI Governor Sanjay Malhotra Drops Big Hint On Tata Sons Listing Row At NDTV World Summit
Big NDTV Summit Impact: RBI Governor's Tata Sons Listing Remark Makes Top Newspaper Headlines
"High Inflation Is Like Tax On Everyone": RBI Governor At NDTV World Summit
AI Assistants Are Both Frightening And Empowering, Says Mike Walsh
Patients with severe vitamin D deficiency were not included in the study. Blood tests at the start of the study and again at three and six months measured the amount of vitamin D in the blood and the response in the immune system's T cells, which play a key role in MS. While researchers are still determining the optimal level of vitamin D in the blood for people with MS, a suggested range of 40 to 60 nanograms per milliliter (ng/ml) has been proposed as a target.Participants taking high doses of vitamin D reached levels within the proposed target, whereas the group taking the low dose did not reach the target. Those taking high dose had a reduction in the percentage of inflammatory T cells related to MS severity.Side effects from the vitamin supplements were minor and did not differ different between those taking high dose and the ones who took low dose, the study found.The study was published online in the journal of Neurology.